(Q38884442)

7 September 2017

title

Cisplatin resistance in human cervical, ovarian and lung cancer cells (English)

1 reference

7 September 2017

1 reference

1 reference

Jianli Chen

1

1 reference

7 September 2017

Charalambos Solomides

2

1 reference

7 September 2017

Hemant Parekh

3

1 reference

7 September 2017

Fiona Simpkins

4

1 reference

7 September 2017

Henry Simpkins

5

1 reference

7 September 2017

publication date

18 April 2015

1 reference

Cancer Chemotherapy and Pharmacology

7 September 2017

published in

1 reference

7 September 2017

volume

75

1 reference

7 September 2017

issue

6

1 reference

7 September 2017

page(s)

1217-1227

1 reference

https://scigraph.springernature.com/pub.10.1007/s00280-015-2739-2

7 September 2017

exact match

0 references

cites work

Drugs five years later. Cisplatin

1 reference

https://api.crossref.org/works/10.1007%2FS00280-015-2739-2

In vitro studies on the mechanisms of oxaliplatin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-015-2739-2

In vitro modulation of cisplatin accumulation in human ovarian carcinoma cells by pharmacologic alteration of microtubules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-015-2739-2

Modulation of cisplatin sensitivity and growth rate of an ovarian carcinoma cell line by bombesin and tumor necrosis factor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-015-2739-2

Increased expression of dihydrodiol dehydrogenase induces resistance to cisplatin in human ovarian carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-015-2739-2

Dihydrodiol dehydrogenases regulate the generation of reactive oxygen species and the development of cisplatin resistance in human ovarian carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-015-2739-2

Overexpression of dihydrodiol dehydrogenase is associated with cisplatin-based chemotherapy resistance in ovarian cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-015-2739-2

Proteomics-based identification of secreted protein dihydrodiol dehydrogenase 2 as a potential biomarker for predicting cisplatin efficacy in advanced NSCLC patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-015-2739-2

The reactive oxygen species--and Michael acceptor-inducible human aldo-keto reductase AKR1C1 reduces the alpha,beta-unsaturated aldehyde 4-hydroxy-2-nonenal to 1,4-dihydroxy-2-nonene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-015-2739-2

c-Jun-NH2-terminal kinase potentiates apoptotic cell death in response to carboplatin in B lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-015-2739-2

Apoptosis by cisplatin requires p53 mediated p38alpha MAPK activation through ROS generation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-015-2739-2

DNA profiling analysis of endometrial and ovarian cell lines reveals misidentification, redundancy and contamination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-015-2739-2

Hypothermia augments reactive oxygen species detected in the guinea pig isolated perfused heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-015-2739-2

Pretreatment mitochondrial priming correlates with clinical response to cytotoxic chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-015-2739-2

Inhibition of AMP-activated protein kinase sensitizes cancer cells to cisplatin-induced apoptosis via hyper-induction of p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-015-2739-2

Resistance to platinum-based chemotherapy in lung cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-015-2739-2

Redox control of resistance to cis-diamminedichloroplatinum (II) (CDDP): protective effect of human thioredoxin against CDDP-induced cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-015-2739-2

Sustained activation of JNK/p38 MAPK pathways in response to cisplatin leads to Fas ligand induction and cell death in ovarian carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-015-2739-2

The CCAAT box binding transcription factor, nuclear factor-Y (NF-Y) regulates transcription of human aldo-keto reductase 1C1 (AKR1C1) gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-015-2739-2

10.1007/S00280-015-2739-2

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

7 September 2017

1004262791

0 references

1 reference